Sattar Yasar, Hamza Mohammad, Yasmin Farah, Jabeen Sidra, Patel Neel, Ishaq Syed, Alyami Bandar, Ul Hussain Hassan, Rehan Syeda Tayyaba, Shuja Syed Hasan, Khan Zayeema, Bahar Yasemin, Elgendy Islam Y, Gonuguntla Karthik, Thyagaturu Harshith, Kawsara Akram, Felpel Kevin, Daggubati Ramesh, Alraies M Chadi
Department of Cardiology, West Virginia University Morgantown, WV 26506, USA.
Department of Internal Medicine, Albany Medical Center Albany, NY 12208, USA.
Am J Cardiovasc Dis. 2024 Apr 15;14(2):54-69. doi: 10.62347/PORE5631. eCollection 2024.
Transcatheter aortic valve replacement (TAVR) has been highly increased as the recommended option for patients with a high surgical risk. This study aims to commit a systematic review and meta-analysis to assess the outcomes in severe aortic stenosis patients following emergency transcatheter aortic valve replacement (emergent TAVR) compared to elective TAVR or eBAV followed by elective TAVR.
We conducted a systematic literature search of PubMed, Embase, Cochrane CENTRAL, CINAHL, Science Direct, and Google Scholar. We included nine studies in the latest analysis that reported the desired outcomes. Outcomes were classified into primary outcomes: 30-day all-cause mortality and 30-day readmission rate, and secondary outcomes, which were further divided into (a) peri-procedural outcomes, (b) vascular outcomes, and (c) renal outcomes. Statistical analysis was performed using Stata v.17 (College State, TX) software.
A total of 44,731 patients with severe aortic stenosis were included (emergent TAVR n = 4502; control n = 40045). 30-day mortality was significantly higher in the emergent TAVR group (OR: 2.62; 95% CI = 1.76-3.92; P < 0.01). Regarding post-procedural outcomes, the length of stay was significantly higher in the emergent TAVR group (Hedges's g: +4.73 days; 95% CI = +3.35 to +6.11; P < 0.01). With respect to vascular outcomes, they were similar in both groups. Regarding renal outcomes, both acute kidney injury (OR: 2.52; 95% CI = 1.59-4.00; P < 0.01) and use of renal replacement therapy (OR: 2.33; 95% CI = 1.87-2.91; P < 0.01) were significantly higher in emergent TAVR group as compared to the control group.
Our study demonstrated that despite increased 30-day mortality and worse renal outcomes, the post-procedural outcomes were similar in emergent and elective TAVR groups. The increased mortality and worse renal outcomes are likely due to hemodynamic instability in the emergent group. The similarity of post-procedural outcomes is evidence of the safety of TAVR even in emergent settings.
经导管主动脉瓣置换术(TAVR)作为手术风险高的患者的推荐选择,其应用已大幅增加。本研究旨在进行系统评价和荟萃分析,以评估与择期TAVR或球囊扩张式主动脉瓣成形术(eBAV)后择期TAVR相比,严重主动脉瓣狭窄患者接受急诊经导管主动脉瓣置换术(急诊TAVR)后的结局。
我们对PubMed、Embase、Cochrane CENTRAL、CINAHL、Science Direct和谷歌学术进行了系统的文献检索。我们在最新分析中纳入了9项报告了预期结局的研究。结局分为主要结局:30天全因死亡率和30天再入院率,以及次要结局,次要结局进一步分为(a)围手术期结局、(b)血管结局和(c)肾脏结局。使用Stata v.17(德克萨斯州大学站)软件进行统计分析。
共纳入44,731例严重主动脉瓣狭窄患者(急诊TAVR组n = 4502;对照组n = 40045)。急诊TAVR组的30天死亡率显著更高(OR:2.62;95%CI = 1.76 - 3.92;P < 0.01)。关于术后结局,急诊TAVR组的住院时间显著更长(Hedges's g:+4.73天;95%CI = +3.35至+6.11;P < 0.01)。关于血管结局,两组相似。关于肾脏结局,急诊TAVR组的急性肾损伤(OR:2.52;95%CI = 1.59 - 4.00;P < 0.01)和肾脏替代治疗的使用(OR:2.33;95%CI = 1.87 - 2.91;P < 0.01)均显著高于对照组。
我们的研究表明,尽管急诊TAVR组的30天死亡率增加且肾脏结局更差,但其术后结局与择期TAVR组相似。死亡率增加和肾脏结局更差可能是由于急诊组的血流动力学不稳定。术后结局的相似性证明了即使在急诊情况下TAVR的安全性。